Maria Leia Smith

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number RE48959
- Issue date Mar 8, 2022
- SEAGEN INC.
- Maria Leia Smith
Information Patent Grant
Detection and treatment of CD30+ cancers
- Patent number 10,444,241
- Issue date Oct 15, 2019
- Seattle Genetics, Inc.
- Tina Albertson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number 9,783,608
- Issue date Oct 10, 2017
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number 9,228,026
- Issue date Jan 5, 2016
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection and treatment of pancreatic, ovarian and other cancers
- Patent number 9,120,854
- Issue date Sep 1, 2015
- Seattle Genetics, Inc.
- Maureen Ryan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
- Publication number 20240247059
- Publication date Jul 25, 2024
- Seagen Inc.
- Maria Leia SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
- Publication number 20240024499
- Publication date Jan 25, 2024
- Ardeagen Corporation
- Maria Leia SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MSLN BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING T...
- Publication number 20240024502
- Publication date Jan 25, 2024
- Ardeagen Corporation
- May Kung SUTHERLAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
- Publication number 20200165335
- Publication date May 28, 2020
- Seattle Genetics, Inc.
- Maria Leia Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DETECTION AND TREATMENT OF CD30+ CANCERS
- Publication number 20200110091
- Publication date Apr 9, 2020
- Seattle Genetics, Inc.
- Tina Albertson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20180079810
- Publication date Mar 22, 2018
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20160185858
- Publication date Jun 30, 2016
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Detection and Treatment of Pancreatic, Ovarian and Other CD70 Posi...
- Publication number 20160003847
- Publication date Jan 7, 2016
- Seattle Genetics, Inc.
- Maureen Ryan
- G01 - MEASURING TESTING
Information Patent Application
DETECTION AND TREATMENT OF CD30+ CANCERS
- Publication number 20140377286
- Publication date Dec 25, 2014
- Seattle Genetics, Inc.
- Tina Albertson
- G01 - MEASURING TESTING
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20130259860
- Publication date Oct 3, 2013
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DETECTION AND TREATMENT OF PANCREATIC, OVARIAN AND OTHER CANCERS
- Publication number 20110300131
- Publication date Dec 8, 2011
- Seattle Genetics, Inc.
- Maureen Ryan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods and Composition for Treating Diseases Targeting Prominin-1...
- Publication number 20100040637
- Publication date Feb 18, 2010
- Karen Van Orden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Maria Leia Smith

Person

Patents Grantslast 30 patents

Humanized antibodies to LIV-1 and use of same to treat cancer

Detection and treatment of CD30+ cancers

Humanized antibodies to LIV-1 and use of same to treat cancer

Humanized antibodies to LIV-1 and use of same to treat cancer

Detection and treatment of pancreatic, ovarian and other cancers

Patents Applicationslast 30 patents

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

ANTI-MSLN BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING T...

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

DETECTION AND TREATMENT OF CD30+ CANCERS

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

Detection and Treatment of Pancreatic, Ovarian and Other CD70 Posi...

DETECTION AND TREATMENT OF CD30+ CANCERS

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

DETECTION AND TREATMENT OF PANCREATIC, OVARIAN AND OTHER CANCERS

Methods and Composition for Treating Diseases Targeting Prominin-1...